Drug Information

Drug General Information
Drug ID
D0U0SK
Former ID
DIB008415
Drug Name
GZ402668
Drug Type
Antibody
Indication Multiple scierosis [ICD9: 340; ICD10:G35] Phase 1 [524983]
Target and Pathway
Target(s) CAMPATH-1 antigen Target Info [551419], [551871]
NetPath Pathway IL2 Signaling Pathway
References
Ref 524983ClinicalTrials.gov (NCT02282826) A First-in-human, Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis. U.S. National Institutes of Health.
Ref 551419Characterization of a Next Generation Anti-CD52 Antibody. Neurology. April 6, 2015 vol. 84 no. 14.
Ref 551871Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.